Showing results (111-120 of 318) with videos related to

Sort By:
Pageof 32
Thoracic Cancer|February 6, 2018
Correlation analysis of mesenchymal-epithelial transition factor protein and human epidermal growth receptor 2 protein expression in 1479 cases of lung adenocarcinoma in ChinaLin Yang, Yiqun Che, Lei Guo, et al.
Thoracic Cancer|January 30, 2018
Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinomaYixiang Zhu, Puyuan Xing, Shouzheng Wang, et al.
BMC Musculoskeletal Disorders|June 5, 2020
Association of ESR1 polymorphism rs2234693 and rs9340799 with postmenopausal osteoporosis in a Chinese populationJin Shu, Junling Li, Yujuan Fu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 11, 2011
[Weekly administration of gemcitabine and docetaxel combinations in the treatment of advanced non-small cell lung cancer]Junling Li, Yilong Wu, Longyun Li, et al.
Chinese Medical Journal|May 10, 2023
Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysisYixiang Zhu, Chengcheng Liu, Ziyi Xu, et al.
Thoracic Cancer|January 15, 2016
Phase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancerJianliang Yang, Yuankai Shi, Xiangru Zhang, et al.
International Journal of Molecular Sciences|February 29, 2020
Dynamics and Endocytosis of Flot1 in <i>Arabidopsis</i> Require CPI1 FunctionYangyang Cao, Qizouhong He, Zengxing Qi, et al.
Theriogenology|May 17, 2025
Induction of feline fetal fibroblasts into pluripotent stem cells using cat-derived reprogramming factorsJian Qin, Nannan Sun, Yitong Wang, et al.
Thoracic Cancer|September 19, 2017
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective studyShufei Yu, Yan Wang, Junling Li, et al.
Frontiers in Oncology|June 17, 2021
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in <i>EGFR</i>-Mutant Lung AdenocarcinomaTeng Li, Xiaocong Pang, Junyun Wang, et al.
Pageof 32